JPWO2020111268A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020111268A5
JPWO2020111268A5 JP2020557880A JP2020557880A JPWO2020111268A5 JP WO2020111268 A5 JPWO2020111268 A5 JP WO2020111268A5 JP 2020557880 A JP2020557880 A JP 2020557880A JP 2020557880 A JP2020557880 A JP 2020557880A JP WO2020111268 A5 JPWO2020111268 A5 JP WO2020111268A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
composition according
edema
crystalline form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020557880A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020111268A1 (ja
JP7196931B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/046893 external-priority patent/WO2020111268A1/ja
Publication of JPWO2020111268A1 publication Critical patent/JPWO2020111268A1/ja
Publication of JPWO2020111268A5 publication Critical patent/JPWO2020111268A5/ja
Application granted granted Critical
Publication of JP7196931B2 publication Critical patent/JP7196931B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020557880A 2018-11-30 2019-11-29 (3s)-3-[2-(6-アミノ-2-フルオロピリジン-3-イル)-4-フルオロ-1h-イミダゾール-5-イル]-7-[5-クロロ-2-(1h-テトラゾール-1-イル)フェニル]-2,3-ジヒドロインドリジン-5(1h)-オンの新規結晶 Active JP7196931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018224434 2018-11-30
JP2018224434 2018-11-30
PCT/JP2019/046893 WO2020111268A1 (ja) 2018-11-30 2019-11-29 (3s)-3-[2-(6-アミノ-2-フルオロピリジン-3-イル)-4-フルオロ-1h-イミダゾール-5-イル]-7-[5-クロロ-2-(1h-テトラゾール-1-イル)フェニル]-2,3-ジヒドロインドリジン-5(1h)-オンの新規結晶

Publications (3)

Publication Number Publication Date
JPWO2020111268A1 JPWO2020111268A1 (ja) 2021-10-14
JPWO2020111268A5 true JPWO2020111268A5 (https=) 2022-08-12
JP7196931B2 JP7196931B2 (ja) 2022-12-27

Family

ID=70853323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020557880A Active JP7196931B2 (ja) 2018-11-30 2019-11-29 (3s)-3-[2-(6-アミノ-2-フルオロピリジン-3-イル)-4-フルオロ-1h-イミダゾール-5-イル]-7-[5-クロロ-2-(1h-テトラゾール-1-イル)フェニル]-2,3-ジヒドロインドリジン-5(1h)-オンの新規結晶

Country Status (16)

Country Link
US (1) US20210395250A1 (https=)
EP (1) EP3888653A4 (https=)
JP (1) JP7196931B2 (https=)
KR (1) KR20210097119A (https=)
CN (1) CN113226312A (https=)
AU (1) AU2019390094A1 (https=)
BR (1) BR112021010476A2 (https=)
CA (1) CA3121447A1 (https=)
IL (1) IL283481A (https=)
MX (1) MX2021006147A (https=)
NZ (1) NZ776666A (https=)
PH (1) PH12021551219A1 (https=)
SG (1) SG11202105697SA (https=)
TW (1) TWI826599B (https=)
WO (1) WO2020111268A1 (https=)
ZA (1) ZA202103692B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022125869A1 (en) * 2020-12-11 2022-06-16 Board Of Regents, The University Of Texas System Compositions and methods of making cocrystals using dielectric heating with dispersive and distributive mixing
JP2024125436A (ja) * 2021-07-20 2024-09-19 小野薬品工業株式会社 イミダゾール化合物の製造方法
TWI833610B (zh) * 2022-03-21 2024-02-21 大陸商上海濟煜醫藥科技有限公司 三并環類化合物製備方法及其中間體

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2630677C2 (ru) * 2011-12-21 2017-09-12 Оно Фармасьютикал Ко., Лтд. Соединения
JP2016093285A (ja) 2014-11-13 2016-05-26 株式会社ユニバーサルエンターテインメント 遊技機
MX385021B (es) * 2014-12-10 2025-03-14 Ono Pharmaceutical Co Derivado de dihidroindolizinona.
JP6992284B2 (ja) * 2016-06-06 2022-01-13 小野薬品工業株式会社 ジヒドロインドリジノン誘導体を含有する医薬組成物

Similar Documents

Publication Publication Date Title
JPWO2020111268A5 (https=)
RU2018139276A (ru) Полиморфные модификации n-[(3-фтор-4-метоксипиридин-2-ил)метил]-3-(метоксиметил)-1-({ 4-[(2-оксопиридин-1-ил)метил]фенил} метил)пиразол-4-карбоксамида и их соли
RU2020121152A (ru) Твердые формы ингибитора калликреина плазмы и их соли
JP2015528798A5 (https=)
RU2020121150A (ru) Твердые формы ингибитора калликреина плазмы и его солей
AU2018201060B2 (en) 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
JP2014502641A5 (https=)
JP2015524443A5 (https=)
JP2019059760A5 (https=)
JP2019518779A5 (https=)
JP2004534825A5 (https=)
JP2017526727A5 (https=)
RU2009107921A (ru) ТЕРАПЕВТИЧЕСКИЕ СПОСОБЫ ЛЕЧЕНИЯ ВАСКУЛЯРНЫХ ЗАБОЛЕВАНИЙ ГЛАЗ АНТАГОНИСТАМИ Dll4
JP2012532112A5 (https=)
JP2011510014A5 (https=)
JP2016512505A5 (https=)
JP2012533570A5 (https=)
JP2015520151A5 (https=)
JP2014511891A5 (https=)
JP2016539180A5 (https=)
JP2014507455A5 (https=)
JP2015500223A5 (https=)
JP2016505071A5 (https=)
JP2010516700A5 (https=)
EA201100462A1 (ru) Серосвязанные соединения для лечения офтальмологических заболеваний и расстройств